Ameriprise’s BG MEDICINE INC COM STK NEW BGMD Stock Holding History

Ameriprise’s Portfolio BGMD Stock Details BGMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	–	Sell	-218	Closed	-$1K	–	5756
2013 Q2	$1K	Buy	+218	New	+$1.45K	﹤0.01%	5452

Other funds holding BGMD

General Electric Evendale, Ohio $369M AUM 19.65% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

MVP

Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return

CLM

ClearBridge LLC (Maryland) Baltimore, Maryland $329M AUM 9.73% 1-Year Est. Return

VFS

VSR Financial Services Overland Park, Kansas $607M AUM 0.85% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Ameriprise's BGMD Position: Q3 2013 in Review

Ameriprise sold out of BG MEDICINE INC COM STK NEW (BGMD) in Q3 2013, closing a stake of 218 shares — an estimated $1K sold.

Ameriprise first reported a position in BGMD in Q2 2013 and held it in 1 quarter. The position peaked at $1K in Q2 2013. 23 funds tracked by Wall St. Rank hold BGMD as of Q3 2013.

Ameriprise reported no remaining BG MEDICINE INC COM STK NEW position as of Q3 2013 after selling out during the quarter.
Ameriprise sold 218 BG MEDICINE INC COM STK NEW shares in Q3 2013, an estimated $1K.
Ameriprise first reported a position in BG MEDICINE INC COM STK NEW in Q2 2013 and held it in 1 quarter.
Ameriprise's BG MEDICINE INC COM STK NEW position peaked at $1K in Q2 2013.
23 funds tracked by Wall St. Rank held BG MEDICINE INC COM STK NEW as of Q3 2013.

Based on Ameriprise's 13F filing for Q3 2013, filed 14 Nov 2013.